Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion.

[1]  I. Nakagawa,et al.  Effect of Pitavastatin on Preventing Ischemic Complications with Carotid Artery Stenting: A Multicenter Prospective Study—EPOCH-CAS Study , 2014, CardioVascular and Interventional Radiology.

[2]  A. Abizaid,et al.  Randomized comparison of distal and proximal cerebral protection during carotid artery stenting. , 2013, JACC. Cardiovascular interventions.

[3]  G. Esposito,et al.  Operator's experience is the most efficient embolic protection device for carotid artery stenting. , 2013, Circulation. Cardiovascular interventions.

[4]  Jaicer Gonçalves Rolo,et al.  Flow Reversal Versus Filter Protection: A Pilot Carotid Artery Stenting Randomized Trial , 2013, Circulation. Cardiovascular interventions.

[5]  J. Schofer,et al.  Impact of asymptomatic cerebral lesions in diffusion-weighted magnetic resonance imaging after carotid artery stenting. , 2013, JACC. Cardiovascular interventions.

[6]  E. Stabile,et al.  Proximal endovascular occlusion for carotid artery stenting. , 2013, The Journal of cardiovascular surgery.

[7]  J. Peinado,et al.  A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. , 2012, Journal of vascular surgery.

[8]  J. Schofer,et al.  The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. , 2012, Journal of the American College of Cardiology.

[9]  N. Vukasinovic,et al.  New Ischemic Brain Lesions on Diffusion-Weighted MRI after Carotid Artery Stenting with Filter Protection: Frequency and Relationship with Plaque Morphology , 2012, American Journal of Neuroradiology.

[10]  Raimund Erbel,et al.  [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[11]  D. Andreini,et al.  Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. , 2011, Journal of the American College of Cardiology.

[12]  J. Birkmeyer,et al.  Operator experience and carotid stenting outcomes in Medicare beneficiaries. , 2011, JAMA.

[13]  George Howard,et al.  Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) , 2011, Stroke.

[14]  D. Scheinert,et al.  Safety and effectiveness of the INVATEC MO.MA® proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  W. Nammas,et al.  Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. , 2010, Journal of the American College of Cardiology.

[16]  G. Moneta.  Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial , 2010 .

[17]  M. Maeda,et al.  Cerebral ischemic lesions detected with diffusion-weighted magnetic resonance imaging after carotid artery stenting: Comparison of several anti-embolic protection devices. , 2009, Neurologia medico-chirurgica.

[18]  N. Rudarakanchana,et al.  Asymptomatic Carotid Surgery Trial-2 (ACST-2): rationale for a randomised clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with asymptomatic carotid artery stenosis. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[20]  A. Kastrup,et al.  New Brain Lesions After Carotid Stenting Versus Carotid Endarterectomy: A Systematic Review of the Literature , 2008, Stroke.

[21]  A. van der Lugt,et al.  Diffusion-weighted imaging to compare different cerebral protection devices in carotid artery stenting. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[22]  G. Schroth,et al.  Periprocedural Embolic Events Related to Carotid Artery Stenting Detected by Diffusion-Weighted MRI: Comparison between Proximal and Distal Embolus Protection Devices , 2007, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[23]  T. Hölzenbein,et al.  Protected carotid-artery stenting versus endarterectomy in high-risk patients , 2005, European Surgery.

[24]  Andreas Kastrup,et al.  Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection Devices: A Systematic Review of the Literature , 2003, Stroke.

[25]  M E Moseley,et al.  New magnetic resonance imaging methods for cerebrovascular disease: Emerging clinical applications , 2000, Annals of neurology.

[26]  M. Egger,et al.  The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.

[27]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.